V Chapman
Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis.
Chapman, V; Markides, H; Sagar, DR; Xu, L; Kay, A; Burston, JJ; Mapp, P; Morris, RH; Kehoe, O; El Haj, AJ
Authors
H Markides
DR Sagar
L Xu
A Kay
JJ Burston
P Mapp
RH Morris
Oksana Kehoe o.kehoe@keele.ac.uk
AJ El Haj
Abstract
Background: Mesenchymal stem cells (MSCs) have a therapeutic potential for the treatment of osteoarthritic (OA) joint pathology and pain. The aims of this study were to determine the influence of a passage number on the effects of MSCs on pain behaviour and cartilage and bone features in a rodent model of OA. Methods: Rats underwent either medial meniscal transection (MNX) or sham surgery under anaesthesia. Rats received intra-articular injection of either 1.5?×?106late passage MSCs labelled with 10?µg/ml SiMAG, 1.5?×?106late passage mesenchymal stem cells, the steroid Kenalog (200?µg/20?µL), 1.5?×?106early passage MSCs, or serum-free media (SFM). Sham-operated rats received intra-articular injection of SFM. Pain behaviour was quantified until day 42 postmodel induction. Magnetic resonance imaging (MRI) was used to localise the labelled cells within the knee joint. Results: Late passage MSCs and Kenalog attenuated established pain behaviour in MNX rats, but did not alter MNX-induced joint pathology at the end of the study period. Early passage MSCs exacerbated MNX-induced pain behaviour for up to one week postinjection and did not alter joint pathology. Conclusion: Our data demonstrate for the first time the role of a passage number in influencing the therapeutic effects of MSCs in a model of OA pain.
Citation
Chapman, V., Markides, H., Sagar, D., Xu, L., Kay, A., Burston, J., …El Haj, A. (2017). Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis. Stem Cells International, 2905104 - ?. https://doi.org/10.1155/2017/2905104
Acceptance Date | Sep 7, 2017 |
---|---|
Publication Date | Dec 24, 2017 |
Journal | Stem Cells International |
Print ISSN | 1687-966X |
Publisher | Hindawi |
Pages | 2905104 - ? |
DOI | https://doi.org/10.1155/2017/2905104 |
Publisher URL | https://www.hindawi.com/journals/sci/2017/2905104/ |
Files
A El Haj - Therapeutic benefit for late but not early passage....pdf
(4.9 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
AB0102 POTENTIAL BIOMARKERS TO PREDICT TNF INHIBITORS OUTCOME IN PSORIATIC ARTHRITIS
(2023)
Presentation / Conference
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search